Search research articles
Contact Us
Filters
Showing results (51-60 of 151) with videos related to
Page
of 16
Sort By:
Therapeutic Drug Monitoring
|
May 10, 2017
Rationale for Therapeutic Drug Monitoring of Biopharmaceuticals in Inflammatory Diseases
Gilles Paintaud, Christophe Passot, David Ternant, et al.
British Journal of Clinical Pharmacology
|
January 19, 2022
Is CD25 blockade optimal in kidney transplant patients treated with basiliximab? A target-mediated drug disposition model
Olivier Le Tilly, Philippe Gatault, Christophe Baron, et al.
Clinical Pharmacokinetics
|
March 10, 2004
Population pharmacokinetics and Bayesian estimation of mycophenolic acid concentrations in stable renal transplant patients
Chantal Le Guellec, Hélène Bourgoin, Matthias Büchler, et al.
Therapeutic Drug Monitoring
|
July 14, 2017
Therapeutic Drug Monitoring of Biopharmaceuticals May Benefit From Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Modeling
Christophe Passot, Mieke F Pouw, Denis Mulleman, et al.
British Journal of Clinical Pharmacology
|
June 23, 2011
Influence of methotrexate on infliximab pharmacokinetics and pharmacodynamics in ankylosing spondylitis
David Ternant, Denis Mulleman, Francine Lauféron, et al.
Bioanalysis
|
August 3, 2017
Development and validation of an enzyme-linked immunosorbent assay to measure free eculizumab concentration in serum
Christophe Passot, Céline Desvignes, David Ternant, et al.
Bioanalysis
|
March 26, 2021
A robust enzyme-linked immunosorbent assay to measure serum ramucirumab concentrations
Céline Desvignes, David Ternant, Thierry Lecomte, et al.
British Journal of Clinical Pharmacology
|
May 22, 2019
Nonlinear pharmacokinetics of rituximab in non-Hodgkin lymphomas: A pilot study
David Ternant, Hélène Monjanel, Yann Venel, et al.
Clinical Pharmacokinetics
|
October 6, 2019
Non-Linear Rituximab Pharmacokinetics and Complex Relationship between Rituximab Concentrations and Anti-Neutrophil Cytoplasmic Antibodies (ANCA) in ANCA-Associated Vasculitis: The RAVE Trial Revisited
Amina Bensalem, Denis Mulleman, Gilles Paintaud, et al.
Cancer Chemotherapy and Pharmacology
|
March 3, 2018
A novel way to manage trastuzumab cardiotoxicity
Diaddin Hamdan, François Darrouzain, Theodora Bejan-Angoulvant, et al.
Page
of 16
Search research articles
Search
Showing results (51-60 of 151) with videos related to
Sort By:
Page
of 16
Therapeutic Drug Monitoring
|
May 10, 2017
Rationale for Therapeutic Drug Monitoring of Biopharmaceuticals in Inflammatory Diseases
Gilles Paintaud, Christophe Passot, David Ternant, et al.
British Journal of Clinical Pharmacology
|
January 19, 2022
Is CD25 blockade optimal in kidney transplant patients treated with basiliximab? A target-mediated drug disposition model
Olivier Le Tilly, Philippe Gatault, Christophe Baron, et al.
Clinical Pharmacokinetics
|
March 10, 2004
Population pharmacokinetics and Bayesian estimation of mycophenolic acid concentrations in stable renal transplant patients
Chantal Le Guellec, Hélène Bourgoin, Matthias Büchler, et al.
Therapeutic Drug Monitoring
|
July 14, 2017
Therapeutic Drug Monitoring of Biopharmaceuticals May Benefit From Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Modeling
Christophe Passot, Mieke F Pouw, Denis Mulleman, et al.
British Journal of Clinical Pharmacology
|
June 23, 2011
Influence of methotrexate on infliximab pharmacokinetics and pharmacodynamics in ankylosing spondylitis
David Ternant, Denis Mulleman, Francine Lauféron, et al.
Bioanalysis
|
August 3, 2017
Development and validation of an enzyme-linked immunosorbent assay to measure free eculizumab concentration in serum
Christophe Passot, Céline Desvignes, David Ternant, et al.
Bioanalysis
|
March 26, 2021
A robust enzyme-linked immunosorbent assay to measure serum ramucirumab concentrations
Céline Desvignes, David Ternant, Thierry Lecomte, et al.
British Journal of Clinical Pharmacology
|
May 22, 2019
Nonlinear pharmacokinetics of rituximab in non-Hodgkin lymphomas: A pilot study
David Ternant, Hélène Monjanel, Yann Venel, et al.
Clinical Pharmacokinetics
|
October 6, 2019
Non-Linear Rituximab Pharmacokinetics and Complex Relationship between Rituximab Concentrations and Anti-Neutrophil Cytoplasmic Antibodies (ANCA) in ANCA-Associated Vasculitis: The RAVE Trial Revisited
Amina Bensalem, Denis Mulleman, Gilles Paintaud, et al.
Cancer Chemotherapy and Pharmacology
|
March 3, 2018
A novel way to manage trastuzumab cardiotoxicity
Diaddin Hamdan, François Darrouzain, Theodora Bejan-Angoulvant, et al.
Page
of 16